Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 06AITTAIPEI428, TAIWAN INVITES COMMENTS FROM DRUG COMPANIES

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #06AITTAIPEI428.
Reference ID Created Released Classification Origin
06AITTAIPEI428 2006-02-12 01:27 2011-08-23 00:00 UNCLASSIFIED American Institute Taiwan, Taipei
VZCZCXYZ0000
RR RUEHWEB

DE RUEHIN #0428/01 0430127
ZNR UUUUU ZZH
R 120127Z FEB 06
FM AIT TAIPEI
TO RUEHC/SECSTATE WASHDC 8484
INFO RUEHBJ/AMEMBASSY BEIJING 4655
RUEHUL/AMEMBASSY SEOUL 7598
RUEHKO/AMEMBASSY TOKYO 7418
RUEHGZ/AMCONSUL GUANGZHOU 8964
RUEHHK/AMCONSUL HONG KONG 5857
RUEHOK/AMCONSUL OSAKA KOBE 0357
RUESLE/AMCONSUL SHANGHAI 8364
RUCPDOC/DEPT OF COMMERCE WASHDC
UNCLAS AIT TAIPEI 000428 
 
SIPDIS 
 
SIPDIS 
 
DEPT PASS USTR 
DEPT FOR EAP/TC AND EB/MTA 
USDOC FOR 4430/ITA/MAC/MBMORGAN 
USTR FRO TIM WINELAND AND G BLUE 
 
E.O. 12958: N/A 
TAGS: ETRD ECON KPRP KTDB TW
SUBJECT: TAIWAN INVITES COMMENTS FROM DRUG COMPANIES 
 
REF: 05 TAIPEI 4685 
 
1. SUMMARY. Joseph Damond VP International Affairs of the 
Pharmaceutical Research and Manufacturers of America (PHRMA) 
met with Bureau of National Health Insurance (BNHI) and Dept 
of Health (DOH) officials Jan 19-20 to discuss PHRMA market 
access concerns in Taiwan. They discussed separation of 
prescribing and dispensing of drugs, public expenditures on 
health care and the high number of prescriptions per doctor 
visit, the high percentage use of generic drugs, and 
transparency in drug pricing. PHRMA also voiced concerns that 
new regulations were being adopted without adequate 
consultation with the drug industry. DOH and BNHI officials 
agreed to allow private sector comments earlier in the 
regulatory process and to hold regular consultations with 
industry and AIT. Damond later met with AIT Director and 
conveyed similar points. END SUMMARY 
 
MARKET ACCESS, AND DRUG PRESCRIBING 
----------------------------------- 
 
2. In a meeting with BNHI Vice President Huang San-Kuei, 
PHRMA representatives Joe Damond and Heather Clark raised the 
limited market access U.S. drug companies have in Taiwan, the 
lack of separation between drug prescribing and dispensing in 
Taiwan hospitals (i.e. hospital pharmacists dispense drugs 
prescribed by hospital doctors encouraging over-prescribing 
to augment hospital revenue), the high number of 
prescriptions per doctor visit (seldom under six), the high 
rate of generic drug reimbursement which encourages the use 
of generics, and low health expenditure in Taiwan. BNHI noted 
that even in the U.S. there is a "black hole" effect due to 
the discount that state governments demand from the drug 
companies. (Note: black hole refers to the excess 
reimbursement over the real cost of the drug-the extra money 
is kept by the hospitals). 
 
3. PHRMA stated that Taiwan reimburses generics at 80 percent 
of cost versus only 20-30 percent in the U.S. Generic drugs 
are 50 percent of the U.S. market by volume but only 12 
percent of market by value. This gives U.S. drug companies 
more incentive to develop new drugs. BNHI stated that because 
drug prices are set according to Pharmaceutical Affairs Law 
article 49 implementation rule 67.1 there is little 
flexibility. 
 
4. PHRMA also opposed a plan to classify new drug 
reimbursement into three categories and hoped the authorities 
would adopt a more transparent pricing system in-line with 
international practice. 
 
AGREED: MORE DIALOGUE 
--------------------- 
 
5. PHRMA met the following day with DOH Vice Minister Chen 
Shi-Chong to request a delay in the implementation of 
regulations and procedures to allow the drug industry more 
time to comment. PHRMA VP Damond reiterated the same points 
he brought up with BNHI VP Huang earlier concerning 
separation of prescribing and dispensing and the high 
reimbursement rate for generic drugs. Chen said that drug 
prices take up 26 percent of healthcare costs and the 
government had put a 5 percent cap on national health 
insurance expenditure growth. He re-affirmed DOH's intent to 
hold regular meetings with industry and AIT as proposed by 
AIT in November 2005. 
 
6. Chen then said he would welcome industry comment under the 
following conditions: 
a. when new drugs are introduced to Taiwan 
b. when looking for ways to minimize NHI budget and prices 
for drugs already on the market 
c. when looking for suggestions that would encourage proper 
drug prescribing by physicians. 
 
 
PHRMA PRESENTS AIT DIRECTOR SAME 
-------------------------------- 
 
7. Following their meeting with DOH vice minister Chen, PHRMA 
reps met with AIT Director and requested his support on the 
above mentioned issues. 
 
8. COMMENT. The positive feedback from DOH and BNHI and the 
fact that heads of both agencies will remain after the latest 
cabinet shuffle improves the chances for continued dialogue 
with PHRMA and the drug industry. However, the entrenched 
interests both in the pharmaceutical industry and medical 
field make it unlikely that either BNHI or DOH will move soon 
to separate drug prescribing from dispensing or to correct 
the overuse of generic medicines.  END COMMENT 
 
 
DAVISON 
 
 
 
DAVISON